Memantina Maxmind (Memantine Hydrochloride)

Memantine hydrochloride acts as a non‑competitive antagonist at the NMDA receptor, blocking excessive calcium influx caused by overstimulation of glutamate. This reduces excitotoxic neuronal injury and helps preserve synaptic function in patients with Alzheimer’s disease.

The dosage of Memantina Maxmind is determined by the prescribing clinician based on the patient’s clinical condition, renal function and tolerability. The prescriber will set the appropriate dose and titration schedule.

Safety data for memantine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Memantina Maxmind, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from cholinesterase inhibitors such as donepezil. While cholinesterase inhibitors enhance acetylcholine activity, memantine reduces glutamate‑mediated excitotoxicity. Both classes may be used together for complementary effects in moderate to severe Alzheimer’s disease.

Memantina Maxmind should be stored at ambient temperature below 25 °C, in the original packaging, and protected from moisture and direct sunlight to maintain product stability.

Memantina Maxmind is taken orally, usually once daily after a gradual dose‑escalation period as directed by the prescriber. The tablets should be swallowed whole with water and not crushed or chewed.

Serious risks include seizures, severe allergic reactions (such as anaphylaxis or Stevens‑Johnson syndrome), hallucinations, and cardiac arrhythmias. Patients should be monitored for these events, and any sudden changes in neurological or cardiac status should prompt immediate medical evaluation.

Memantina Maxmind is contraindicated in patients with known hypersensitivity to memantine hydrochloride or any of its excipients. Caution is advised in individuals with severe renal impairment, uncontrolled seizures, or those taking other NMDA antagonists.